Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen

Teresa Fasciana1, Andrea Cortegiani2, Mariachiara Ippolito2

  • 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialities, University of Palermo, 90127 Palermo, Italy.

Insights

Candida auris, a multidrug-resistant yeast, causes invasive infections. Accurate identification is crucial to prevent its spread, as misidentification can complicate patient management and transmission control.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Candida auris is a multidrug-resistant yeast causing invasive infections globally, particularly in critically ill patients.
  • Its ease of spread, environmental persistence, and antifungal resistance present significant challenges for infection control and patient management.
  • Accurate and early identification of Candida auris colonization is vital for preventing transmission.

Purpose of the Study:

  • To provide an overview of critical aspects related to Candida auris.
  • To highlight challenges in laboratory identification and susceptibility profiling.
  • To inform strategies for containing the spread of Candida auris infections.

Main Methods:

  • Review of literature on Candida auris.
  • Discussion of sample collection techniques.
  • Evaluation of culture-dependent and independent identification methods.
  • Analysis of antifungal susceptibility profiling.

Main Results:

  • Candida auris is frequently misidentified as related pathogens, complicating diagnosis.
  • Effective containment relies on precise laboratory identification and susceptibility testing.
  • Environmental persistence and multidrug resistance underscore the need for stringent infection control.

Conclusions:

  • Early and accurate identification of Candida auris is essential for effective infection control.
  • Standardized laboratory methods are needed to overcome identification challenges.
  • Understanding susceptibility profiles is key to guiding antifungal therapy and managing outbreaks.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
10.6K